Amer A Beg

4PUBLICATIONS
52CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 11, 2026
KRAS-G12C inhibition-induced enrichment of MHC-Ihigh immune-active tumor cells directs immune-effector TME development to augment therapeutic efficacy.

|Dec 19, 2025
Distinct Tumor-Immune Ecologies in Patients with Lung Cancer Predict Progression and Define a Clinical Biomarker of Therapy Response.

Sandhya Prabhakaran, Chandler D Gatenbee, Mark Robertson-Tessi

|Aug 27, 2024
RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis.

Nana Adjoa Ben-Crentsil, Wazim Mohammed Ismail, Maria E Balasis

|Feb 09, 2023
Combination IFNβ and Membrane-Stable CD40L Maximize Tumor Dendritic Cell Activation and Lymph Node Trafficking to Elicit Systemic T-cell Immunity.

Hong Zheng, Xiaoqing Yu, Mohammed L Ibrahim

Pageof 1

Frequent Collaborators

3 joint publications

Mohammed L Ibrahim

3 joint publications

Theresa A Boyle

2 joint publications

Hong Zheng

2 joint publications

Xiaoqing Yu